Fumito Tsuji
President,
SFJ Pharma Japan K.K.
SFJ Pharmaceuticals
Japan
Biography
Mr. Tsuji joined SFJ Pharmaceuticals in July of 2010 with over 25 years of clinical development experience across multiple therapeutic indications in the pharmaceutical industry. Mr. Tsuji was Head of Clinical Development at Schering-Plough KK, where he oversaw the Clinical Trials of hypercholesterolemia compound (Ezetimib) from Phase I studies through PMDA approval and malignant glioma compound (Temozolomide) from Phase II study through PMDA approval. Mr. Tsuji specializes in building development strategies for the approval of drugs. Mr. Tsuji has a Master’s Degree from Kanazawa University in Pharmaceutical Sciences.
Research Interest
global pharmaceutical / life sciences, Business management
